Center Conducts Six Blood Drives Across Pottstown

Posted on 05 January 2011. Tags: ,

Donor gifts save lives.

POTTSTOWN PA – Six blood drives scheduled by the Miller-Keystone Blood Center will be held in various Pottstown and Douglassville PA locations between Jan. 12 and 20 (2011). Appointments are required and may be made by calling the blood bank at 610-926-6060.

These events have been added to The Post calendar.

On the schedule are:

  • Jan. 12 (Wednesday) from 1-6 p.m. at French Creek Elementary, 3590 Coventryville Rd., Pottstown;
  • Jan. 13 (Thursday) from 8:30 a.m. to 5:20 p.m. at Diamond Credit Union, 1600 Medical Dr., Lower Pottsgrove (PA) Township;
  • Jan. 14 (Friday) from 8 a.m. to 12:40 p.m. at Pottstown Borough Hall, 100 High St., Pottstown;
  • Jan. 15 (Saturday) from 10 a.m. to 2 p.m. at Monarch Fire Company, 50 Pennsylvania Ave., Douglassville;
  • Jan. 19 (Wednesday) from 8-11 a.m. at HCR Manor Care, 724 Charlotte St., Pottstown; and
  • Jan. 20 (Thursday) from 3-7 p.m. at Mountain View Chapel, 68 Old Douglass Dr., Douglassville.
Share

One Response to “Center Conducts Six Blood Drives Across Pottstown”

Trackbacks/Pingbacks

  1. Wednesday’s Headlines In The Post | The Sanatoga Post says:
    January 5, 2011 at 7:01 am

    [...] Center Conducts Six Blood Drive Across Pottstown Six different blood drives, one of them in Lower Pottsgrove, will be conducted during the next two weeks by the Miller-Keystone Blood Center. Can you spare a pint to save a life? [...]


From Our Sponsors

RSS Health News

  • U.S. task force: End routine prostate cancer screening May 22, 2012
    NEW YORK (Reuters) - A task force advising the U.S. government on Monday recommended against routine use of the prostate-cancer screening test called PSA, or prostate specific antigen, for lack of a discernible health benefit. […]
  • Fake drugs threaten gains made in war on malaria May 21, 2012
    LONDON (Reuters) - Low-quality and fake anti-malarial drugs flooding into markets in Asia and Africa are driving drug resistance and threatening gains made in the fight against the disease in the past decade, according to a study by global health experts. […]
  • U.S. Catholic groups sue to block contraception mandate May 21, 2012
    (Reuters) - The University of Notre Dame and dozens of other Catholic institutions sued President Barack Obama's administration on Monday to block a government regulation that requires employers to provide health insurance coverage for contraceptives to employees. […]
  • "Pre-diabetes," diabetes rising among U.S. teens May 21, 2012
    By Amy Norton NEW YORK (Reuters Health) - The percentage of U.S. teenagers with "pre-diabetes" or full-blown type 2 diabetes has more than doubled in recent years -- though obesity and other heart risk factors have held steady, government researchers reported Monday. […]
  • Tired surgical residents may up error risk: study May 21, 2012
    NEW YORK (Reuters Health) - A small study suggests surgeons in training are still tired enough to raise their risk of making significant errors, despite new guidelines limiting their work hours. […]
  • Lung cancer tests advised for some heavy smokers May 21, 2012
    NEW YORK (Reuters Health) - New recommendations from chest and cancer doctors call for lung cancer screening in older adults with a long history of smoking a pack a day or more -- but also highlight the possible harms of screening, including a high risk of false positive tests. […]
  • Not all ICUs need a specialist at night: study May 21, 2012
    NEW YORK (Reuters Health) - Among hospital intensive care units (ICUs) with a daytime physician specially trained in critical care, adding a specialist to cover the night shift does not improve patients' survival, according to a new study. […]
  • FDA staff sends mixed message on J&J drug Xarelto May 21, 2012
    WASHINGTON (Reuters) - U.S. drug reviewers had mixed opinions about whether Johnson & Johnson blood thinner Xarelto reduced the risk of new heart attacks and strokes in people with heart problems, setting the stage for heated debate by outside experts later this week. […]
  • Peregrine soars as cancer drug meets trial goal May 21, 2012
    (Reuters) - Peregrine Pharmaceuticals Inc said results from a mid-stage trial showed that its key experimental drug performed better than standard chemotherapy in lung cancer patients who had not responded to primary therapy, sending its shares up 36 percent. […]
  • Sigmoidoscopy an option for colon cancer screening May 21, 2012
    NEW YORK (Reuters Health) - Screening for colon cancer using a flexible tube -- which is less invasive and more convenient than colonoscopy -- may also help prevent new cases and deaths from the disease, a new study suggests. […]